These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36761724)

  • 21. Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma.
    Peng S; Chen S; Hu W; Mei J; Zeng X; Su T; Wang W; Chen Z; Xiao H; Zhou Q; Li B; Xie Y; Hu H; He M; Han Y; Tang L; Ma Y; Li X; Zhou X; Dai Z; Liu Z; Tan J; Xu L; Li S; Shen S; Li D; Lai J; Peng B; Peng Z; Kuang M
    Cancer Immunol Res; 2022 Jun; 10(6):728-744. PubMed ID: 35476700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy.
    Huff AL; Longway G; Mitchell JT; Andaloori L; Davis-Marcisak E; Chen F; Lyman MR; Wang R; Mathew J; Barrett B; Rahman S; Leatherman J; Yarchoan M; Azad NS; Yegnasubramanian S; Kagohara LT; Fertig EJ; Jaffee EM; Armstrong TD; Zaidi N
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 38063199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines.
    Kang Y; Zhang W; Yu Q; Gao L; Quan J; Gu F; Wu Y; Tian Y; Wu Z; Shao S; Zhou H; Duan S; Zhou Y; Zhang L; Gao X; Tian H; Yao W
    Cancer Immunol Immunother; 2023 Aug; 72(8):2741-2755. PubMed ID: 37119260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy.
    Yang X; Fan J; Wu Y; Ma Z; Huang J; Zhang Y; Zhou Z; Mo F; Liu X; Yuan H; Xu Y; Pan L; Chen S
    Nanomedicine; 2021 Oct; 37():102443. PubMed ID: 34303839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Driving neoantigen-based cancer vaccines for personalized immunotherapy into clinic: A burdensome journey to promising land.
    Yu G; He X; Li X; Wu Y
    Biomed Pharmacother; 2022 Sep; 153():113464. PubMed ID: 36076493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell biology and its role in tumor immunotherapy.
    Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
    J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
    van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
    Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
    Ichimiya S; Fujimura A; Masuda M; Masuda S; Yasumatsu R; Umebayashi M; Tanaka H; Koya N; Nakagawa S; Yew PY; Yoshimura S; Onishi H; Nakamura M; Nakamura Y; Morisaki T
    Immunol Invest; 2022 Jul; 51(5):1498-1514. PubMed ID: 34486463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer.
    Kinkead HL; Hopkins A; Lutz E; Wu AA; Yarchoan M; Cruz K; Woolman S; Vithayathil T; Glickman LH; Ndubaku CO; McWhirter SM; Dubensky TW; Armstrong TD; Jaffee EM; Zaidi N
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.
    Supabphol S; Li L; Goedegebuure SP; Gillanders WE
    Expert Opin Investig Drugs; 2021 May; 30(5):529-541. PubMed ID: 33641576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering neoantigen vaccines to improve cancer personalized immunotherapy.
    Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X
    Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
    Gautam SK; Kumar S; Dam V; Ghersi D; Jain M; Batra SK
    Semin Immunol; 2020 Feb; 47():101391. PubMed ID: 31952903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
    Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
    World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dendritic cell vaccines loaded with autologous tumor lysates for solid tumors].
    Kamigaki T; Takahara M; Teruya T
    Nihon Rinsho; 2017 Feb; 75(2):288-294. PubMed ID: 30562866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8
    Park KS; Nam J; Son S; Moon JJ
    Biomaterials; 2021 Jul; 274():120844. PubMed ID: 33962217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
    Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
    Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report.
    Shao J; Liu Q; Shen J; Qian X; Yan J; Zhu Y; Qiu X; Lu C; Cen L; Tian M; Du J; Liu B
    Front Immunol; 2022; 13():799026. PubMed ID: 35273594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.